Juvenile Idiopathic Arthritis Diagnostic Global Market Report 2025
상품코드:1751031
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
소아 특발성 관절염 진단 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 자가면역질환과 염증성질환의 유병률 증가, 정부 및 의료기관의 노력, 원격의료 및 디지털 헬스 플랫폼의 대두 등에 기인한다고 생각됩니다.
자가면역 질환의 유병률 상승은 향후 몇 년 동안 소아 특발성 관절염 진단 시장의 성장을 크게 촉진할 것으로 예측됩니다. 자가면역 질환은 면역 체계가 신체의 건강한 세포를 잘못 공격하여 염증, 조직 손상 및 만성 건강 합병증을 일으키는 질환입니다. 자가 면역 질환의 이환율 증가는 환경 유인, 유전적 요인 및 라이프 스타일 변화의 조합과 관련이 있습니다. 소아 특발성 관절염의 경우, 이러한 장애는 면역 체계가 관절의 활액 조직을 표적으로 삼아 염증과 잠재적인 관절 손상을 유발합니다. 73,241,305명의 피보험자 중 630만 4,340명이 적어도 하나의 자가면역질환으로 진단되었으며, 유병률은 8.61%에 달하며, 자가면역질환의 이환율 증가가 소아 특발성 관절염 진단 수요를 견인하고 있습니다.
주요 기업은 제품 제공을 확대하고 연구 능력을 강화하고 세계 시장에서의 프레즌스 강화를 위해 전략적 파트너십을 맺는 것이 늘어나고 있습니다. 예를 들어, 2024년 11월 캐나다에 본사를 둔 생명공학 회사인 Augurex Life Sciences Corp.는 14-3-3 η(eta) 바이오마커를 사용하여 류마티스 관절염(RA)의 진단 및 관리를 개선하기 위해 미국에 본사를 둔 진단 서비스 회사인 Quest Diagnostics와 파트너십을 체결했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 태와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 소아 특발성 관절염 진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 소아 특발성 관절염 진단 시장 : 성장률 분석
세계의 소아 특발성 관절염 진단 시장 실적 : 규모와 성장, 2019-2024
세계의 소아 특발성 관절염 진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 소아 특발성 관절염 진단 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 소아 특발성 관절염 진단 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
혈청학적 검사
화상 검사
유전자 검사
세계의 소아 특발성 관절염 진단 시장 : 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
분자진단
면역 측정
플로우 사이토메트리
세계의 소아 특발성 관절염 진단 시장 : 서비스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
진단 서비스
컨설팅 서비스
실험실 서비스
세계의 소아 특발성 관절염 진단 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원의 검사실
진단센터
연구기관
세계의 소아 특발성 관절염 진단 시장 : 혈청학적 검사유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
류마토이드 인자(RF) 검사
항핵항체(ANA) 검사
적혈구 침강 속도(ESR) 검사
C 반응성 단백질(CRP) 검사
항시클릭 시트룰린화 펩티드(항-CCP) 검사
전혈구 수(CBC)
세계의 소아 특발성 관절염 진단 시장 : 화상 검사유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
X선
자기 공명 영상법(MRI)
초음파
컴퓨터 단층 촬영(CT) 스캔
뼈 신티그래피(뼈 스캔)
세계의 젊은 성 특발성 관절염 진단 시장 : 유전자 검사유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
HLA-B27 유전자 마커 검사
모든 엑솜 시퀀싱(WES)
차세대 시퀀싱(NGS)
중합효소 연쇄반응(PCR)에 기초한 검사
제7장 지역별/국가별 분석
세계의 소아 특발성 관절염 진단 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 소아 특발성 관절염 진단 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
소아 특발성 관절염 진단 시장 : 경쟁 구도
소아 특발성 관절염 진단 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Agilent Technologies : 개요, 제품 및 서비스, 전략 및 재무 분석
Sartorius AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sysmex Corporation
Bio-Rad Laboratories
Beckman Coulter Life Sciences
DiaSorin
Miltenyi Biotec
Cytek Biosciences
BD Biosciences
Angstrom Biotech
Sony Biotechnology
Theradiag
J. Mitra
Chimera Biotech
Stratedigm
Apogee Flow Systems
Avecon Healthcare
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
소아 특발성 관절염 진단 시장 2029 : 새로운 기회를 제공하는 국가
소아 특발성 관절염 진단 시장 2029 : 새로운 기회를 제공하는 부문
소아 특발성 관절염 진단 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Juvenile idiopathic arthritis (JIA) diagnosis refers to the medical procedures and tests used to detect JIA, a chronic autoimmune disorder in children that leads to persistent joint inflammation, pain, and stiffness, which can result in long-term joint damage and mobility challenges. It occurs when the immune system mistakenly attacks the body's own joint tissues due to a combination of genetic and environmental factors, causing inflammation that, if left untreated, can lead to growth problems, vision issues, and a diminished quality of life.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary methods for diagnosing juvenile idiopathic arthritis include serological tests, imaging tests, and genetic tests. Serological tests analyze blood to detect specific markers that suggest inflammation or autoimmune activity related to JIA. Key diagnostic technologies include molecular diagnostics, immunoassays, and flow cytometry. Diagnostic services, consultation services, and laboratory services are provided in settings such as hospital laboratories, diagnostic centers, and research institutions.
The juvenile idiopathic arthritis diagnostic market research report is one of a series of new reports from The Business Research Company that provides juvenile idiopathic arthritis diagnostic market statistics, including the juvenile idiopathic arthritis diagnostic industry's global market size, regional shares, competitors with a juvenile idiopathic arthritis diagnostic market share, detailed juvenile idiopathic arthritis diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the juvenile idiopathic arthritis diagnostic industry. This juvenile idiopathic arthritis diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The juvenile idiopathic arthritis diagnostic market size has grown strongly in recent years. It will grow from$4.75 billion in 2024 to $5.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the rising prevalence of juvenile idiopathic arthritis, increased awareness of pediatric autoimmune disorders, early detection initiatives, greater healthcare investments, and a heightened focus on pediatric care.
The juvenile idiopathic arthritis diagnostic market size is expected to see strong growth in the next few years. It will grow to$6.32 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to growing collaborations between research institutions, rising demand for early and accurate diagnostic solutions, increasing prevalence of autoimmune and inflammatory disorders, initiatives by government and healthcare organizations, and the rise of telemedicine and digital health platforms. Key trends in the forecast period include technological advancements, improvements in diagnostic technologies, personalized treatment approaches, and innovations in diagnostic tools.
The rising prevalence of autoimmune disorders is expected to significantly drive the growth of the juvenile idiopathic arthritis (JIA) diagnostic market in the coming years. Autoimmune disorders are conditions in which the immune system erroneously attacks the body's healthy cells, causing inflammation, tissue damage, and chronic health complications. The increasing incidence of autoimmune diseases is linked to a combination of environmental triggers, genetic factors, and lifestyle changes. In the case of juvenile idiopathic arthritis, these disorders cause the immune system to target the synovial tissue in joints, leading to inflammation and potential joint damage. For instance, a report from Versorgungsatlas.de, a Germany-based interactive online platform, indicated that in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, representing a prevalence rate of 8.61%. Therefore, the growing incidence of autoimmune disorders is driving the demand for juvenile idiopathic arthritis diagnostics.
Leading companies in the juvenile idiopathic arthritis diagnostic market are increasingly forming strategic partnerships to expand their product offerings, enhance research capabilities, and strengthen their global market presence. These partnerships focus on advancing early detection and more accurate diagnosis. For example, in November 2024, Augurex Life Sciences Corp., a biotechnology company based in Canada, entered into a partnership with Quest Diagnostics, a US-based diagnostic services company, to improve the diagnosis and management of rheumatoid arthritis (RA) through the use of the 14-3-3η (eta) biomarker. As part of the collaboration, Quest Diagnostics will validate and offer a lab-developed test in the United States based on Augurex's 14-3-3η biomarker, which helps detect elevated levels of the 14-3-3η protein-associated with rheumatoid arthritis and a higher risk of joint damage and disease severity.
In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. to offer surgeons and patients a comprehensive range of musculoskeletal procedural solutions and advanced technologies. This merger aims to improve the overall continuum of care, expand the companies' global operations, and significantly enhance their portfolios in arthritis and orthopedic treatments. NuVasive, a US-based company, specializes in developing medical devices and procedures focused on orthopedic and idiopathic conditions.
Major players in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech, Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, and Avecon Healthcare.
North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in juvenile idiopathic arthritis diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the juvenile idiopathic arthritis diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The juvenile idiopathic arthritis diagnostic market consists of revenues earned by entities by providing services such as clinical evaluations, blood tests, ophthalmologic screenings, bone density scans, and synovial fluid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The juvenile idiopathic arthritis diagnostic market also includes sales of bone density scanners, AI-based diagnostic software, imaging equipment, and biomarker-based diagnostic panels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Juvenile Idiopathic Arthritis Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on juvenile idiopathic arthritis diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for juvenile idiopathic arthritis diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The juvenile idiopathic arthritis diagnostic market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Serological Tests; Imaging Tests; Genetic Tests
2) By Technology: Molecular Diagnostics; Immunoassays; Flow Cytometry
3) By Services: Diagnostic Services; Consultation Services; Laboratory Services
4) By Application: Hospital Laboratories; Diagnostic Centres; Research Institutes
3. Juvenile Idiopathic Arthritis Diagnostic Market Trends And Strategies
4. Juvenile Idiopathic Arthritis Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Juvenile Idiopathic Arthritis Diagnostic Growth Analysis And Strategic Analysis Framework
5.1. Global Juvenile Idiopathic Arthritis Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate Analysis
5.4. Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Juvenile Idiopathic Arthritis Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Juvenile Idiopathic Arthritis Diagnostic Total Addressable Market (TAM)
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Juvenile Idiopathic Arthritis Diagnostic Market
9.1. China Juvenile Idiopathic Arthritis Diagnostic Market Overview
9.2. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Juvenile Idiopathic Arthritis Diagnostic Market
10.1. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Juvenile Idiopathic Arthritis Diagnostic Market
11.1. Japan Juvenile Idiopathic Arthritis Diagnostic Market Overview
11.2. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Juvenile Idiopathic Arthritis Diagnostic Market
12.1. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market
13.1. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Juvenile Idiopathic Arthritis Diagnostic Market
14.1. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Overview
14.2. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market
15.1. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview
15.2. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Juvenile Idiopathic Arthritis Diagnostic Market
16.1. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market
21.1. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview
21.2. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Juvenile Idiopathic Arthritis Diagnostic Market
22.1. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Juvenile Idiopathic Arthritis Diagnostic Market
23.1. North America Juvenile Idiopathic Arthritis Diagnostic Market Overview
23.2. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Juvenile Idiopathic Arthritis Diagnostic Market
24.1. USA Juvenile Idiopathic Arthritis Diagnostic Market Overview
24.2. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Juvenile Idiopathic Arthritis Diagnostic Market
26.1. South America Juvenile Idiopathic Arthritis Diagnostic Market Overview
26.2. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Juvenile Idiopathic Arthritis Diagnostic Market
27.1. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Juvenile Idiopathic Arthritis Diagnostic Market
28.1. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Overview
28.2. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Juvenile Idiopathic Arthritis Diagnostic Market
29.1. Africa Juvenile Idiopathic Arthritis Diagnostic Market Overview
29.2. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Juvenile Idiopathic Arthritis Diagnostic Market Competitive Landscape And Company Profiles
